Impact of inactivated COVID-19 vaccines on viral shedding in B.1.617.2(Delta)variant-infected patients  

作　　者：Zhiliang Hu Yi Yin Kai Wang Miaomiao Xu Chengyuan Ding Yan Song Changhua Yi Junwei Li Yongxiang Yi Zhihang Peng 

机构地区：[1]Nanjing Infectious Disease Center,the Second Hospital of Nanjing,Nanjing University of Chinese Medicine,Nanjing 210003 China [2]Center for Global Health,School of Public Health,Nanjing Medical University,Nanjing 211166 China [3]School of Public Health,Nanjing Medical University,Nanjing 211166,China [4]The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China

出　　处：《Science China(Life Sciences)》2022年第12期2556-2559,共4页中国科学（生命科学英文版）

基　　金：supported by the National Natural Science Foundation of China(82073673);the National Science and Technology Major Project of China(2018ZX10715002-004-002,2018ZX10713001-001);the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD);Key Research and Development Program of Department of Health of Jiangsu(ZDB2020036);Project of Nanjing Infectious Disease Clinical Medical Center Construction(NA2021062071)。

摘　　要：Dear Editor,The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2)has waged a global pandemic. As of April 15, 2022, more than 500 million cases of COVID-19 had been reported, with more than 6 million deaths. The ultimate arsenal to fight against this pandemic is highly effective vaccines (Bok et al.,2021;Sadarangani et al., 2021).

关 键 词：vaccines ACUTE 

分 类 号：R186[医药卫生—流行病学]